PFM
PacWest Financial Management Portfolio holdings
AUM
$1.69B
This Quarter Return
+1.96%
1 Year Return
+8.84%
3 Year Return
+19.16%
5 Year Return
–
10 Year Return
–
AUM
$1.69B
AUM Growth
+$1.69B
(+934%)
Cap. Flow
+$48.8M
Cap. Flow
% of AUM
2.89%
Top 10 Holdings %
Top 10 Hldgs %
31.22%
Holding
84
New
5
Increased
27
Reduced
48
Closed
2
Top Buys
| 1 |
Vanguard International Dividend Appreciation ETF
VIGI
|
$32.8M |
| 2 |
General Mills
GIS
|
$11M |
| 3 |
GE Aerospace
GE
|
$10.1M |
| 4 |
Cisco
CSCO
|
$9.03M |
| 5 |
Procter & Gamble
PG
|
$5.69M |
Top Sells
Sector Composition
| 1 | Technology | 12.91% |
| 2 | Healthcare | 12.28% |
| 3 | Financials | 10.02% |
| 4 | Consumer Discretionary | 7.6% |
| 5 | Consumer Staples | 7.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Exxon Mobil
XOM
$487B
| $22.4M | 1.32% |
24,783
+258
| +1% | +$233K |
|
27
SPDR Portfolio Short Term Corporate Bond ETF
SPSB
$8.42B
| $21.9M | 1.3% |
71,635
-16,660
| -19% | -$5.09M |
|
28
Starbucks
SBUX
$100B
| $21.8M | 1.29% |
39,337
-1,650
| -4% | -$916K |
|
29
RTX Corp
RTX
$212B
| $21.3M | 1.26% |
19,467
-447
| -2% | -$490K |
|
30
Accenture
ACN
$162B
| $21.2M | 1.25% |
18,058
-105
| -0.6% | -$123K |
|
31
AbbVie
ABBV
$372B
| $21.1M | 1.25% |
33,699
-364
| -1% | -$228K |
|
32
Pfizer
PFE
$141B
| $21M | 1.25% |
64,783
+2,512
| +4% | +$816K |
|
33
NVIDIA
NVDA
$4.24T
| $20.9M | 1.24% |
19,600
+10
| +0.1% | +$10.7K |
|
34
SPDR S&P MidCap 400 ETF Trust
MDY
$23.7B
| $20.4M | 1.21% |
6,747
-413
| -6% | -$1.25M |
|
35
Merck
MRK
$210B
| $20.3M | 1.2% |
34,458
+147
| +0.4% | +$86.5K |
|
36
Amphenol
APH
$133B
| $19.4M | 1.15% |
28,825
-1,490
| -5% | -$1M |
|
37
Costco
COST
$418B
| $19.2M | 1.14% |
11,982
+7
| +0.1% | +$11.2K |
|
38
NextEra Energy, Inc.
NEE
$148B
| $18.9M | 1.12% |
15,800
+110
| +0.7% | +$131K |
|
39
Becton Dickinson
BDX
$55.3B
| $18.5M | 1.1% |
11,205
+295
| +3% | +$488K |
|
40
BCE
BCE
$23.3B
| $18.4M | 1.09% |
42,535
+1,210
| +3% | +$523K |
|
41
Fastenal
FAST
$57B
| $16.8M | 1% |
35,800
-640
| -2% | -$301K |
|
42
Amgen
AMGN
$155B
| $16.5M | 0.98% |
11,288
-20
| -0.2% | -$29.2K |
|
43
Novo Nordisk
NVO
$251B
| $16.5M | 0.97% |
45,905
+1,215
| +3% | +$436K |
|
44
Bank of New York Mellon
BK
$74.5B
| $16.3M | 0.97% |
34,490
-1,215
| -3% | -$576K |
|
|
PX
45
DELISTED
Praxair Inc
PX
| $16.3M | 0.96% |
13,872
-191
| -1% | -$224K |
|
46
Medtronic
MDT
$119B
| $16.2M | 0.96% |
22,747
+1,079
| +5% | +$769K |
|
47
Mastercard
MA
$538B
| $15.9M | 0.94% |
15,397
-798
| -5% | -$824K |
|
48
Consolidated Edison
ED
$35.4B
| $15.8M | 0.94% |
21,470
-158
| -0.7% | -$116K |
|
49
Stryker
SYK
$150B
| $15.6M | 0.92% |
12,980
-550
| -4% | -$659K |
|
50
Southern Company
SO
$102B
| $15.2M | 0.9% |
30,990
+915
| +3% | +$450K |
|